We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App





Sansure Presents Future of Pathogen Identification and Disease Diagnosis

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: Advanced diagnostics solutions for various infections highlighted at Medlab Middle East 2024 (Photo courtesy of Sansure)
Image: Advanced diagnostics solutions for various infections highlighted at Medlab Middle East 2024 (Photo courtesy of Sansure)

Sansure Biotech (Hunan, China) is highlighting its advanced diagnostic solutions for respiratory tract infection, HPV infection, reproductive tract infection, blood-borne infection and gastrointestinal infection at Medlab Middle East 2024.

Sansure is introducing Surelite – its first CE-IVDR-certified automated CLIA system. The Surelite 8 and Surelite 16 are compact automated CLIA systems that deliver rapid and accurate diagnostic results in as fast as 15 minutes. The smart design, featuring an all-in-one cartridge and a broad spectrum of assays, matches various clinical demands with no extra consumables and no waste. Visitors to the Sansure booth at Medlab Middle East 2024 can also experience the iPonatic III Portable Molecular Workstation alongside the Q-POC Platform. iPonatic III, born in the age of the pandemic, is now finding application in the diagnosis of various infections, including respiratory tract infection (RTI), sexually transmitted infection (STI), and more. On the other hand, the Q-POC Platform is a molecular diagnosis instrument that offers accurate PCR results within 25 minutes. The multiple target points facilitate the testing and evaluation of severe and critical cases.

At Medlab Middle East 2024, Sansure is highlighting its high-throughput, high-precision extraction systems which enable a complete workflow of sample preprocessing and nucleic acid extraction. The Natch CS2 fully automated nucleic acid extraction system is a powerful nucleic acid purification system with an extremely simple workflow. Similarly, the Natch 48 nucleic acid extraction system with advanced magnetic bead technology makes it easy to operate this automatic nucleic acid extractor. Among other products on display at the show is the MA-6000 real-time fluorescence quantitative PCR system equipped with innovative hardware, structure, and optimized software to deliver higher-quality results. MA-6000 ensures extraordinary detection sensitivity, extends the application of thermal cycler from nucleic acid to biotinylated protein, and expands a brand new path for multiplex diagnosis in the clinical field.

Related Links:
Sansure Biotech

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
MTHFR Mutation Test
REALQUALITY THROMBO MTHFR
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.